May 2025 Newsletter — Progress with a noteworthy therapy; presymptomatic diagnoses;…and more!

Table of Contents

  • Progress with ASO therapy development for individuals with the intronic mutation

  • Navigating a presymptomatic diagnosis

  • Advancing APBD research depends on sustained funding

  • Elizabeth LeBlanc joins Foundation team as genetic counseling intern

  • Upcoming Chats for Patients and Caregivers

 
 
Previous
Previous

July 2025 Newsletter — New addition to our team, updated prevalence estimates…and more!

Next
Next

April 2025 Newsletter —Rallying for Research, COMBINEDBrain partnership…and more!